Diagnostic concordance and discordance in digital pathology: a systematic review and meta-analysis
AS Azam, IM Miligy, PKU Kimani, H Maqbool… - Journal of Clinical …, 2021 - jcp.bmj.com
Background Digital pathology (DP) has the potential to fundamentally change the way that
histopathology is practised, by streamlining the workflow, increasing efficiency, improving …
histopathology is practised, by streamlining the workflow, increasing efficiency, improving …
[HTML][HTML] Elevated MMP9 expression in breast cancer is a predictor of shorter patient survival
Purpose MMP9 is a matricellular protein associated with extracellular matrix (ECM)
remodelling, that promotes tumour progression, and modulates the activity of cell adhesion …
remodelling, that promotes tumour progression, and modulates the activity of cell adhesion …
[HTML][HTML] Predictors of pathological complete response to neoadjuvant treatment and changes to post-neoadjuvant HER2 status in HER2-positive invasive breast …
The response of human epidermal growth factor receptor2 (HER2)-positive breast cancer
(BC) patients to anti-HER2 targeted therapy is significant. However, the response is not …
(BC) patients to anti-HER2 targeted therapy is significant. However, the response is not …
Invasion in breast lesions: the role of the epithelial–stroma barrier
Despite the significant biological, behavioural and management differences between ductal
carcinoma in situ (DCIS) and invasive carcinoma of the breast, they share many …
carcinoma in situ (DCIS) and invasive carcinoma of the breast, they share many …
Semantic annotation for computational pathology: multidisciplinary experience and best practice recommendations
Recent advances in whole‐slide imaging (WSI) technology have led to the development of a
myriad of computer vision and artificial intelligence‐based diagnostic, prognostic, and …
myriad of computer vision and artificial intelligence‐based diagnostic, prognostic, and …
Overexpression of the cancer stem cell marker CD133 confers a poor prognosis in invasive breast cancer
C Joseph, M Arshad, S Kurozomi, M Althobiti… - Breast Cancer Research …, 2019 - Springer
Purpose CD133/prominin 1 is a cancer stem cell marker associated with cancer progression
and patient outcome in a variety of solid tumours, but its role in invasive breast cancer (BC) …
and patient outcome in a variety of solid tumours, but its role in invasive breast cancer (BC) …
[HTML][HTML] A whole slide image-based machine learning approach to predict ductal carcinoma in situ (DCIS) recurrence risk
Background Breast ductal carcinoma in situ (DCIS) represent approximately 20% of screen-
detected breast cancers. The overall risk for DCIS patients treated with breast-conserving …
detected breast cancers. The overall risk for DCIS patients treated with breast-conserving …
[HTML][HTML] AI-enabled routine H&E image based prognostic marker for early-stage luminal breast cancer
Breast cancer (BC) grade is a well-established subjective prognostic indicator of tumour
aggressiveness. Tumour heterogeneity and subjective assessment result in high degree of …
aggressiveness. Tumour heterogeneity and subjective assessment result in high degree of …
[HTML][HTML] The prognostic significance of immune microenvironment in breast ductal carcinoma in situ
Background The role of different subtypes of tumour infiltrating lymphocytes (TILs) in breast
ductal carcinoma in situ (DCIS) is still poorly defined. This study aimed to assess the …
ductal carcinoma in situ (DCIS) is still poorly defined. This study aimed to assess the …
[HTML][HTML] Retrospective observational study of HER2 immunohistochemistry in borderline breast cancer patients undergoing neoadjuvant therapy, with an emphasis on …
Abstract Background The ASCO/CAP guidance on HER2 testing in breast cancer (BC) has
recently changed. Group 2 tumours with immunohistochemistry score 2+ and HER2/CEP17 …
recently changed. Group 2 tumours with immunohistochemistry score 2+ and HER2/CEP17 …